Synthesis and synergistic antifungal activities of a pyrazoline based ligand and its copper(II) and nickel(II) complexes with conventional antifungals

Microbial Pathogenesis
Imran AliNikhat Manzoor

Abstract

A pyrazoline based ligand; (5-(4-chlorophenyl)-3-phenyl-4, 5-dihydro-1H-pyrazole-1-carbothioamide) has been synthesized by Claisen-Schmidt condensation of acetophenone with p-chlorobenzaldehyde, followed by sodium hydroxide assisted cyclization of the resulting chalcone with thiosemicarbazide. Metal ion complexes of the synthesized ligand were prepared with Cu(II) and Ni(II) metal ions, separately and respectively. Ligand and the metal complexes were characterized by elemental analysis, FT-IR, UV-Vis, (1)HNMR, ESI-MS and (13)CNMR spectroscopic techniques. Molar conductance measurements in DMSO suggested non-electrolytic nature of the complexes. Tetragonally distorted octahedral geometry for copper and octahedral geometry for the nickel complexes was proposed on the basis of UV-Vis spectroscopic studies and magnetic moment measurements. The complexes were investigated for their ability to kill human fungal pathogen Candida by determining MICs (Minimum inhibitory concentrations), inhibition in solid media and ability to produce a possible synergism with conventional most clinically practiced antifungals by disc diffusion assay and FICI (fractional inhibitory concentration index).

References

Mar 1, 1984·Southern Medical Journal·B RoduJ P Gockerman
Jul 14, 1999·Diagnostic Microbiology and Infectious Disease·F M Verduyn LunelA Voss
Jun 26, 2003·Trends in Microbiology·Frank C OddsNeil A R Gow
Mar 31, 2004·Bioorganic & Medicinal Chemistry·Adnan A Bekhit, Tarek Abdel-Aziem
Jun 19, 2004·Journal of Enzyme Inhibition and Medicinal Chemistry·Zahid H ChohanClaudiu T Supuran
Sep 24, 2005·Toxicological Sciences : an Official Journal of the Society of Toxicology·Rocío F CantónMartin van den Berg
May 22, 2007·European Journal of Medicinal Chemistry·R PrabhakaranK Natarajan
May 28, 2009·Antimicrobial Agents and Chemotherapy·Monika SharmaRajendra Prasad
Oct 20, 2009·Microbial Pathogenesis·Aijaz AhmadLuqman A Khan
Apr 10, 2010·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·K AmberM Nikhat
Jun 15, 2011·Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy·Sangamesh A PatilPrema S Badami
Jul 14, 2011·Clinical Epidemiology·Jane KriengkauykiatSanjeet S Dadwal
Oct 13, 2011·Archiv der Pharmazie·Adnan A BekhitAlaa El-Din A Bekhit
Mar 9, 2012·Expert Opinion on Therapeutic Patents·Mohamed R ShaabanAhmad M Farag

❮ Previous
Next ❯

Citations

Jul 3, 2013·Journal of Enzyme Inhibition and Medicinal Chemistry·Jimi Marin Alex, Raj Kumar
May 23, 2015·Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents·Adam ZąbekMałgorzata Jeżowska-Bojczuk
Jun 5, 2016·Fitoterapia·Sheikh ShreazLee Ting Hun
Jun 24, 2016·Microbial Pathogenesis·Rossana de Aguiar CordeiroJosé Júlio Costa Sidrim
Mar 2, 2013·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Seham Y Hassan
Feb 12, 2014·Antimicrobial Agents and Chemotherapy·Rossana de Aguiar CordeiroJosé Júlio Costa Sidrim
Feb 6, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Gergő MótyánÉva Frank
Feb 27, 2020·Future Medicinal Chemistry·Mohamed I ChouiterArtur Ms Silva
Feb 6, 2020·Current Pharmaceutical Design·Imran AliLuciana Scotti
Mar 12, 2020·Polymers·Imran AliJung-Chih Chen
Jan 28, 2021·Critical Reviews in Analytical Chemistry·Negin Fasih RamandiHassan Y Aboul-Enein

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Related Papers

The Journal of General and Applied Microbiology
Sheikh ShreazLuqman Ahmad Khan
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine
Sheikh ShreazLuqman Ahmad Khan
Acta Crystallographica. Section E, Structure Reports Online
Su-Qing Wang, Cheng Kong
Oral Surgery, Oral Medicine, and Oral Pathology
D D DammG A Ferretti
© 2021 Meta ULC. All rights reserved